Trial intelligence / Profile preview

Aminophylline + Furosemide for Diuresis in ICU

NCT05933642Phase 3Unknown

Sponsor
Universiti Malaya
Start
Jul 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of aminophylline in acute kidney injury (AKI), sponsored by Universiti Malaya. Status: unknown.

02

Drugs

aminophylline
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT05933642.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05933642.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call